Blood test may spare unneeded liver biopsies for fatty liver patients
NCT ID NCT05370053
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether giving doctors the results of a blood test called ELF helps them better diagnose advanced liver scarring (fibrosis) in people with fatty liver disease. About 450 patients were randomly assigned to have the ELF test or not during their liver clinic visit. The goal was to see if the test leads to more accurate diagnoses and fewer unnecessary liver biopsies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATTY LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new MRI technique could see inside the Liver's metabolism without a biopsy
- Could a common b vitamin tame fatty liver?
- HIV and fatty liver: a hidden link under the microscope
- Can a sugar test reveal how fatty liver begins in obese adolescents?
- Could a daily dose of citrus fiber tame fatty liver inflammation?
- Fatty liver disease: a new biobank aims to unlock the secrets of a silent epidemic